• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 51 of 100
Lung cancer on the left pulmonary lobe, seen on a frontal X-ray of the chest.
HealthMerck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer
By Sy MukherjeeApril 16, 2018
Hepatitis C drug can cure, if patients can get it
HealthHepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
By Sy MukherjeeApril 12, 2018
Alzheimers-dementia-brain-research
HealthResearchers Just Proposed a Radical New Way of Defining Alzheimer’s. Could It Lead to Better Drugs?
By Sy MukherjeeApril 10, 2018
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
HealthThis Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
By Sy MukherjeeApril 9, 2018
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
HealthWhy Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
By Hallie DetrickApril 9, 2018
US-ECONOMY-STOCK MARKET
HealthWhy Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It
By Sy MukherjeeApril 6, 2018
Flu Vaccine Shortage Continues
HealthFlu Season Is Still Going Strong
By Emily PriceMarch 30, 2018
Neisseria Gonorrhoeae
HealthThe U.K. Just Confirmed Its 1st Case of ‘Super Gonorrhea.’ And It’s Freaking Out Health Experts
By Sy MukherjeeMarch 29, 2018
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthThis Company Beat the Odds to Become One of the World’s Most ‘Innovative’ Drug Giants
By Sy MukherjeeMarch 28, 2018
Pharmaceuticals, Viagra
HealthViagra Just Turned 20. Here’s How Much Money the ED Drug Makes
By Sy MukherjeeMarch 27, 2018
GlaxoSmithKline Is Buying Out Novartis’s Share in Their Consumer Health Joint Venture
HealthGlaxoSmithKline Is Buying Out Novartis’s Share in Their Consumer Health Joint Venture
By David MeyerMarch 27, 2018
Walker For Handicapped Person
HealthDoctors Say They’ve Found a ‘Game Changing’ Stem Cell Treatment for MS
By Hallie DetrickMarch 19, 2018
The Progress We’ve Made Fighting ALS, the Disease Stephen Hawking Suffered From
HealthThe Progress We’ve Made Fighting ALS, the Disease Stephen Hawking Suffered From
By Sy MukherjeeMarch 14, 2018
prescription-drugs-teva-pharmaceutical
HealthWhy U.S. Health Care Costs Are Twice As High As Other High-Income Countries
By Kirsten KorosecMarch 14, 2018
Dow Jones Average Continues Sharp Decline
HealthWhy This Acne Drug Maker’s Stock Is Plummeting Over 60%
By Chris MorrisMarch 5, 2018
1...
  • 49
  • 50
  • 51
  • 52
  • 53
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.